Personal information

No personal information available

Activities

Works (9)

Risk-of-bias assessment protocol BR trial

2023-02-07 | Book chapter
Contributors: Kelly Hendriks-Spoor; Johanna Damen; Jesper Weehuizen
Source: check_circle
Crossref

No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007–2010 Q fever outbreak

International Journal of Epidemiology
2022-10-13 | Journal article
Contributors: Jesper M Weehuizen; Sonja E van Roeden; Sander J Hogewoning; Wim van der Hoek; Marc J M Bonten; Andy I M Hoepelman; Chantal P Bleeker-Rovers; Peter C Wever; Jan Jelrik Oosterheert
Source: check_circle
Crossref

Fluorescence in situ hybridization for detecting Coxiella burnetii in tissue samples from chronic Q fever patients

Clinical Microbiology and Infection
2022-06 | Journal article
Part of ISSN: 1198-743X
Source: Self-asserted source
Jesper Weehuizen

No Influence of Previous <i>Coxiella burnetii</i> Infection on ICU Admission and Mortality in Emergency Department Patients Infected with SARS-CoV-2

Journal of Clinical Medicine
2022-01 | Journal article | Author
Contributors: Jesper Weehuizen; Rik van Spronsen; Andy I. M. Hoepelman; Chantal P. Bleeker-Rovers; Jan Jelrik Oosterheert; Peter C. Wever
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature Communications
2021-12 | Journal article
Part of ISSN: 2041-1723
Source: Self-asserted source
Jesper Weehuizen

Chronic Q fever vertebral osteomyelitis, an underrecognized clinical entity

Infectious Diseases
2021-04-03 | Journal article
Part of ISSN: 2374-4235
Part of ISSN: 2374-4243
Source: Self-asserted source
Jesper Weehuizen

An open‐label cluster‐randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID‐19 (ARCHAIC)—Protocol publication

European Journal of Clinical Investigation
2020-07 | Journal article
Part of ISSN: 0014-2972
Part of ISSN: 1365-2362
Source: Self-asserted source
Jesper Weehuizen
grade
Preferred source (of 2)‎

Efficacy and safety of long-term maraviroc use in a heterogeneous group of HIV-infected patients: A retrospective cohort study

International Journal of Antimicrobial Agents
2019-08 | Journal article
Part of ISSN: 0924-8579
Source: Self-asserted source
Jesper Weehuizen

More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients

Journal of Clinical Virology
2019-07 | Journal article
Part of ISSN: 1386-6532
Source: Self-asserted source
Jesper Weehuizen